Navigation Links
Aderans Research BIO International Press Release

ARI a Key Presence at Recent BIO International Convention

Atlanta, GA (PRWEB) May 31, 2009 -- Aderans Research Institute Inc. (ARI) was a notable presence at the recent BIO International Convention. The leading hair regeneration company joined more than 1,800 companies from 58 countries around the globe at the world's largest annual event for the biotechnology industry, held May 18-21 at the Georgia World Congress Center.

Co-located in Atlanta and Philadelphia, ARI is actively engaged in the study of state-of-the-art cell-based hair regeneration for men and women. The company recently launched Phase 2 of its clinical study to assess the impact of its regenerative cell treatment on pattern hair loss, also known as androgenetic alopecia. Phase 2 of the study is being conducted in six U.S. cities: Atlanta, Boston, New York, Raleigh, Houston, and Washington DC. Phase 1 was conducted exclusively in the United Kingdom.

"Our research is focused on generating a tissue engineering solution to the regeneration of hair," said Kurt Stenn, MD, Vice President and Chief Scientific Officer at ARI. "We're using the hair cells from hair follicles and researching methods to promote their growth in controlled laboratory environments. If successful, we'll then be able to recombine the cells and restore them to the scalp, where they would ultimately elicit hair growth."

A dynamic field on the cutting-edge of the hair restoration industry, cell treatment represents a major advance on traditional hair transplant procedures, promising to overcome a key limitation of conventional transplantation: a finite hair supply for any one person. Through leading edge cell engineering, Aderans Research is pioneering efforts to multiply existing hair cells capable of eliciting hair growth, providing patients with a comprehensive solution to hair loss regardless of the quantity of their existing hair.

About the BIO International Convention:
The BIO International Convention is the largest global event for the biotechnology industry, offering key networking and partnering opportunities, and providing insight on major trends affecting the industry. The convention is produced by BIO, the world's largest biotechnology organization, representing more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and abroad. BIO works to create a favorable policy environment for biotechnological innovation. Its members are involved in marketing, research and development across the healthcare, agriculture, industrial and environmental biotechnology fields.

Learn more at:

About Aderans Research:
Aderans Research is dedicated to solving the pervasive problem of hair loss and becoming the world leader in the research and development of safe, effective cell engineered products for hair regeneration.

With offices in Atlanta and Philadelphia, Aderans Research Institute is a subsidiary of Aderans Company, Ltd, the world's largest wig manufacturer, and an affiliate of Bosley, a global leader in medical hair restoration.

More information on ARI's study outcomes will be released as studies conclude. To see ARI's latest clinical updates, please visit

Additional information on ARI can be found at

Vern Liebmann
Tel: 678.213.1913


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Aderans Research Launches Second Phase of Hair Loss Study
2. Pitt melanoma researchers present novel findings at ASCO
3. Indiana U. research at the American College of Sports Medicine conference
4. UTSA Dean George Perry co-edits textbook chronicling four decades of Alzheimers research
5. Researchers develop light-treatment device to improve sleep quality in the elderly
6. Cancer research partnership between UCSF, MMRF to drive drug development
7. AGA Institute presents cutting-edge research during DDW
8. MU researchers offer insights for advancing health communication through digital media
9. Raymond Tye Named Trustee at Schepens Eye Research Institute
10. 5th International Scientific Symposium on Tourette Syndrome to Focus on Latest Research and Treatment
11. LSUHSC dental researcher funded to develop better dental materials
Post Your Comments:
Related Image:
Aderans Research BIO International Press Release
(Date:6/27/2016)... , ... June 27, 2016 , ... ... mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... to the network of the Tennessee Counseling Association, adding exclusive benefits and promotional ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology: